TimeScale Financial’s Cyclerion Therapeutics CYCN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-1
| Closed | -$9 | – | 634 |
|
|
2022
Q4 | $9 | Hold |
1
| – | – | ﹤0.01% | 590 |
|
|
2022
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 552 |
|
|
2022
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 527 |
|
|
2022
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 530 |
|
|
2021
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 520 |
|
|
2021
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 514 |
|
|
2021
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 517 |
|
|
2021
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 516 |
|
|
2020
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 442 |
|
|
2020
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 466 |
|
|
2020
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 456 |
|
|
2020
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 433 |
|
|
2019
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 517 |
|
|
2019
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 506 |
|
|
2019
Q2 | $0 | Buy |
+1
| New | – | ﹤0.01% | 518 |
|